A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals.
about
Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapyThe role of compensatory mutations in the emergence of drug resistanceAntiviral resistance and the control of pandemic influenzaNeuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spreadPopulation-wide emergence of antiviral resistance during pandemic influenzaImpact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugsStrategies for containing an emerging influenza pandemic in Southeast AsiaA systematic review to identify areas of enhancements of pandemic simulation models for operational use at provincial and local levels.Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic.Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1).Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planningEmergence of drug-resistant influenza virus: population dynamical considerations.Delaying the international spread of pandemic influenza.The impact of prophylaxis of healthcare workers on influenza pandemic burden.The effect of population structure on the emergence of drug resistance during influenza pandemics.Modelling control measures to reduce the impact of pandemic influenza among schoolchildren.Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.Modeling the effects of drug resistant influenza virus in a pandemic.A small community model for the transmission of infectious diseases: comparison of school closure as an intervention in individual-based models of an influenza pandemic.Modelling seasonality and viral mutation to predict the course of an influenza pandemic.Pandemic Risk Assessment Model (PRAM): a mathematical modeling approach to pandemic influenza planning.The impact of mass gatherings and holiday traveling on the course of an influenza pandemic: a computational model.Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective.Predictive and Reactive Distribution of Vaccines and Antivirals during Cross-Regional Pandemic Outbreaks.How to minimize the attack rate during multiple influenza outbreaks in a heterogeneous population.Prioritizing healthcare worker vaccinations on the basis of social network analysis.Translational systems approaches to the biology of inflammation and healing.Stochastic model of an influenza epidemic with drug resistanceOptimality of a time-dependent treatment profile during an epidemic.Understanding the Impact of Interventions to Prevent Antimicrobial Resistant Infections in the Long-Term Care Facility: A Review and Practical Guide to Mathematical Modeling.Host population structure impedes reversion to drug sensitivity after discontinuation of treatment.Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.Predictive models of control strategies involved in containing indoor airborne infections.Population dynamics of epidemic and endemic states of drug-resistance emergence in infectious diseases.Inducing Herd Immunity against Seasonal Influenza in Long-Term Care Facilities through Employee Vaccination Coverage: A Transmission Dynamics Model.Public health measures to control the spread of antimicrobial resistance in Neisseria gonorrhoeae in men who have sex with men.The dynamics of an epidemic model with targeted antiviral prophylaxis.Understanding influenza virus-specific epidemiological properties by analysis of experimental human infections.Optimal antiviral treatment strategies and the effects of resistance.An epidemic model with post-contact prophylaxis of distributed length I. Thresholds for disease persistence and extinction.
P2860
Q27307203-4C397DAF-2873-4D13-AA95-8615825EAA82Q28469058-9C703622-2881-4117-88FE-AE4B75473F59Q28469119-207EEE68-66D9-4ADC-82D8-2410446FF6A2Q28471814-1346577F-AEF5-4402-AF02-8009FBE61F1CQ28472381-D4052330-F8E1-49ED-BD2B-B588BED73C60Q28472846-22CB531C-281D-4C2D-9D6E-1EB6DC7F8936Q29618561-5D9174F1-D83A-4A92-B554-2B6D5318F5B1Q30224678-B5BEA216-251A-485E-A727-12B381CD3B93Q30226721-CE903810-1833-417A-9CEC-2FC8255B332DQ30227845-38E438BA-106F-4EB4-B813-1E20C754F44FQ30230076-C9F0BAAE-D659-4BA3-8B32-5478F8622661Q30353989-D9057859-3567-4121-B4FD-575FAEAA0BB3Q30354068-1A95430E-3674-4269-9FA8-EC52C898B0A2Q30360440-CF5990A5-D6DE-4DD5-8D16-3E758643176DQ30362753-16C58DEF-3DBC-4E71-A6A0-80195AE29853Q30364559-B8922C49-875D-4A6B-9602-78ACAB7F5FCDQ30372938-5E25FF2F-D40D-4201-A9F3-8AFDF4FD3068Q30373057-E83E841F-B2E6-4C9A-B94B-5D86EE0BB00FQ30374058-E6351026-1559-4DB1-9F6B-1E4494B75292Q30385683-6A21B9F3-0A6D-415C-8350-B36B12AAAFF5Q30392042-FE61544C-B902-4AB7-8107-FC825CD5F072Q30397758-CE3D0E4A-3B10-42C3-AB6B-FF302937DF43Q30399379-5D7CBDD6-C3D8-465D-94EB-973FF219291BQ30422471-0B35F80D-68F7-4F87-901F-65CEA9A794FBQ34305125-487BB377-7036-4961-8159-B39ED64C6257Q34509858-8084067C-585B-43B6-95B0-F9AA13333631Q35098770-2427B16B-396A-4120-BD6F-5AE6F5A3CB45Q35644886-7DA7B58E-1F63-4A02-B980-60F91F5A626EQ37122154-F4A64D5D-4886-4DC9-B193-010F15B4988CQ38781267-8CA11CAF-50E0-4C12-927E-8E640E122688Q40084961-F7180825-11CE-42C8-AE45-7EA4C9B1624EQ40138039-6DC604B7-FF7B-4AC8-B587-3C7C2F16B078Q40270663-0564A4A2-03DB-41AF-8F69-6E5D267E0017Q40368149-54D1D391-8BCF-45BB-A3AA-4595050F3EFFQ40809369-9C860915-EAD6-47D4-AA4F-96C823E20209Q41719091-FF6E801B-2880-477C-BE95-E39D8F565295Q42716598-F8AD8B10-AAF8-4E1C-AF91-1A553BE82D62Q44206841-C7A4D48E-B855-48A1-A779-0AD440EAF106Q51653188-B7FD4A0B-DFCE-4E84-9988-9640CC8E1EA1Q51889708-AFAA920E-9EA6-4A48-8679-E59C8A6054B9
P2860
A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
A population-dynamic model for ...... unity-based use of antivirals.
@en
type
label
A population-dynamic model for ...... unity-based use of antivirals.
@en
prefLabel
A population-dynamic model for ...... unity-based use of antivirals.
@en
P2093
P356
P1476
A population-dynamic model for ...... munity-based use of antivirals
@en
P2093
Helen Jackson
Noel Roberts
Penelope Ward
P304
P356
10.1093/JAC/DKG136
P407
P577
2003-03-13T00:00:00Z